U.S., June 12 -- ClinicalTrials.gov registry received information related to the study (NCT07016074) titled 'Inorganic Nitrate (NaNO3) Prevention of Contrast-Associated Acute Kidney Injury' on June 03.
Brief Summary: This pilot study is designed to test the logistics and recruitment of a trial testing the benefit of sodium nitrate in the prevention of contrast-associated kidney injury in a group of patients at high-risk.
Study Start Date: June, 2025
Study Type: INTERVENTIONAL
Condition:
Kidney Injury, Acute
Intervention:
DRUG: Sodium Nitrate
The study drug is sodium nitrate capsule at a dose of 12mmol of nitrate. This medication will be given orally 1-8 hours before the planned contrast administration and then once per day for a tot...